NuScale Power, a developer specializing in compact modular reactors, recently disclosed its second-quarter earnings, revealing a dramatic 99% year-over-year decrease in revenue, bringing the figure down to a mere $75,000. Paradoxically, the company's cash and liquid investment holdings experienced a substantial boost, increasing by $900 million from the previous quarter to reach an impressive $1.9 billion. This significant surge in capital, nearly quadrupling from a year ago, underscores a unique financial trajectory where robust liquidity takes precedence over current revenue performance, largely influenced by strategic stock offerings and long-term project timelines.
NuScale's innovative small modular reactors (SMRs) are designed to be considerably smaller than traditional nuclear power units. Their pre-fabricated nature aims to reduce construction time, labor costs, and overall expenses associated with building nuclear power plants. Each SMR unit generates 77 MWe, offering the flexibility to combine multiple reactors for higher-capacity plants, making them ideal for deployment in remote areas. The company is actively collaborating with Fluor on a project to install six 77 MWe reactors for Romania's RoPower, aiming for a total capacity of 462 MWe. Additionally, NuScale plans to deploy up to six gigawatts of its SMR technology across seven U.S. states for the Tennessee Valley Authority (TVA).
Despite these ambitious projects, NuScale does not anticipate the actual deployment of these SMRs until the early 2030s. Consequently, a significant portion of its current income is derived from front-end engineering and design (FEED) studies, licensing fees, and consulting services related to these future endeavors. The sharp decline in revenue during the first half of 2026 can be attributed to the completion of its FEED Phase 2 work on the RoPower project in late 2025, without immediate comparable projects to compensate for the reduction. This inherent variability explains why revenue fluctuations may not accurately reflect the company's long-term financial health.
The remarkable increase in NuScale's liquidity during the second quarter warrants closer examination. This growth primarily stems from $984.5 million in net proceeds acquired through stock offerings in the first half of 2026. This strategy led to an expansion of Class A shares from 318.5 million at the close of 2025 to 410.4 million by the end of Q2 2026. Furthermore, on August 11, NuScale indicated plans to issue an additional $750 million in shares via an at-the-market offering. Given the fluctuating revenue streams, persistent losses, and the distant timeline for commercial SMR deployment, further share dilution is expected. This situation, coupled with a valuation of 14 times projected 2028 sales and net selling by insiders over the past year, suggests that investors should meticulously evaluate the company's cash utilization and overall financial strategy.
